Childhood Myelodysplastic Syndrome

general

An uncommon hematologic malignancy occurring during childhood. Children present with neutropenia and thrombocytopenia more often than adults, and bone marrow hypocellularity is more often seen in children than adults. Childhood MDS includes persistent cytopenia with less than 20% blasts.

Centers

Active Trials

$699M

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Recurrent Childhood Myelodysplastic Syndrome	5	5
Refractory Childhood Myelodysplastic Syndrome	5	5

Top Centers for Childhood Myelodysplastic Syndrome(12)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	—	55.6
2	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	55.6
3	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	55.6
4	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive	2	—	55.6
5	OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive	—	—	55.6
6	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	2	—	55.6
7	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	55.6
8	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	55.6
9	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	55.6
10	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive	2	$507M	—
11	University of Illinois Cancer CenterChicago, IL	2	$122M	—
12	University of Cincinnati Cancer CenterCincinnati, OH	2	$71M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →